Dexcom (DXCM) Capital Expenditures Growth (5y) (2015 - 2026)
Dexcom (DXCM) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.11 Bn | 18.70 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.50% |
| Mar 31, 2026 | -5.13% |
| Dec 31, 2025 | 11.10% |
| Sep 30, 2025 | 11.17% |
| Jun 30, 2025 | 10.09% |
| Mar 31, 2025 | 21.25% |
| Dec 31, 2024 | 23.09% |
| Sep 30, 2024 | 17.48% |
| Jun 30, 2024 | 7.10% |
| Mar 31, 2024 | 7.68% |
| Dec 31, 2023 | 24.29% |
| Sep 30, 2023 | 16.19% |
| Jun 30, 2023 | 41.78% |
| Mar 31, 2023 | 37.32% |
| Dec 31, 2022 | 29.26% |
| Sep 30, 2022 | 51.63% |
| Jun 30, 2022 | 50.12% |
| Mar 31, 2022 | 34.71% |
| Dec 31, 2021 | 35.44% |
| Sep 30, 2021 | 46.35% |